Brainomix and Endeavor BioMedicines presented positive results on September 8, 2026, from an AI-driven quantitative analysis ...
Insilico Medicine ("Insilico"), a clinical-stage company focused on generative AI-driven drug discovery and development, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results